A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response

Angewandte Chemie - International Edition

Volumn 44, Issue 46, 2005, Pages 7630-7635

  Dziadek, Sebastian ^a   Hobel, Alexandra ^a   Schmitt, Edgar ^a   Kunz, Horst ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antigens; Antitumor agents; Glycopeptides; Synthetic vaccines; T cell epitope

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; CELL CULTURE; EPITAXIAL GROWTH; ONCOGENIC VIRUSES; VACCINES;

ANTITUMOR AGENTS; SYNTHETIC VACCINES; T-CELL EPITOPE;

ANTIGENS;

CA 15-3 ANTIGEN; CANCER VACCINE; EPITOPE; GLYCOPEPTIDE; RECOMBINANT VACCINE; TUMOR ANTIGEN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BIOLOGICAL MODEL; CARBOHYDRATE ANALYSIS; CHEMISTRY; CONFORMATION; IMMUNOLOGY; MOLECULAR GENETICS; STEREOISOMERISM; SYNTHESIS;

ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; CANCER VACCINES; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; EPITOPES, T-LYMPHOCYTE; GLYCOPEPTIDES; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; STEREOISOMERISM; VACCINES, SYNTHETIC;

EID: 28244478566     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200501594     Document Type: Article

References (44)

1. a) J. N. Blattmann, P. D. Greenberg, Science 2004, 305, 200;
2. b) Z. Yu, N. P. Restifo, J. Clin. Invest. 2002, 110, 289;
3. c) P. Moingeon, Vaccine 2001, 19, 1305;
4. d) S. J. Danishefsky, J. A. Allen, Angew. Chem. 2000, 112, 883;
5. Angew. Chem. Int. Ed. 2000, 39, 836;
6. e) R. R. Koganty, M. A. Reddish, B. M. Longenecker, Drug Discovery Today 1996, 1, 190.
7. For a biological background, see the previous Communication in this issue: a) S. Dziadek, D. Kowalczyk, H. Kunz, Angew. Chem. 2005, 117, 7798;
8. Angew. Chem. Int. Ed. 2005, 44, 7624.
9. b) for a short overview, see: S. Dziadek, C. G. Espinola, H. Kunz, Aust. J. Chem. 2003, 50, 519.
10. S. Keil, C. Claus, W. Dippold, H. Kunz, Angew. Chem. 2001, 113, 379;
11. Angew. Chem. Int. Ed. 2001, 40, 366.
12. a) R. N. Germain, Cell 1994, 76, 287;
13. b) J. A. Villadaugos, Mol. Immunol. 2001, 38, 329.
14. K. M. Murphy, A. B. Heimberger, D. Y. Loh, Science 1990, 250, 1720.
15. a) J. Burchell, J. Taylor-Papadimitriou, M. Boshell, S. Gendler, T. Dulig, Int. J. Cancer 1989, 44, 691;
16. b) M. R. Price, F. Hudecz, C. O'Sullivan, R. W. Baldwin, P. M. Edwards, S. B. J. Tendler, Mol. Immunol. 1990, 27, 795;
17. c) D. I. R. Spencer, M. R. Price, S. B. J. Tendler, C. DeMatties, T. R. E. Stadie, F.-G. Hanisch, Cancer Lett. 1996, 100, 11-15.
18. S. H. Itzkowitz, M. Yuan, C. K. Montgomery, T. Kjeldsen, H. K. Takahashi, W. L. Bigbee, Y. S. Kim, Cancer Res. 1989, 49, 197.
19. H. Inoue, Obstet. Gynecol. 1990, 75, 1031.
20. a) I. Takahashi, I. Maehara, T. Kusumoto, M. Yoshida, Y. Kakej, H. Kusumoto, M. Furusawa, K. Suglimacti, Cancer 1993, 72, 18836;
21. b) R. Soares, A. Marinho, F. Schmitt, Pathol. Res. Pract. 1996, 192, 1182.
22. a) I. Brockhausen, Biochim. Biophys. Acta 1999, 1473, 67;
23. I. Brockhausen, Biochem. Soc. Trans. 2003, 31, 318;
24. b) K. O. Lloyd, J. Burchell, V. Kundryashov, B. W. Yin, J. Taylor-Papadimitriou, J. Biol. Chem. 1996, 271, 33325.
25. a) T. F. Orntoft, N. Harvig, N. C. Langklide, Int. J. Cancer 1990, 45, 666;
26. b) J. Taylor-Papadimitriou, J. M. Burchell, T. Plunkett, R. Graham, I. Correa, D. Miles, M. Smith, J. Mammary Gland Biol. 2002, 7, 209;
27. c) F.-G. Hanisch, S. Müller, Glycobiology 2000, 10, 439.
28. a) M. Wagner, H. Kunz, Angew. Chem. 2002, 114, 315;
29. Angew. Chem. Int. Ed. 2002, 41, 317;
30. b) M. Wagner, S. Dziadek, H. Kunz, Chem. Eur. J. 2003, 9, 6018.
31. E. Bayer, W. Rapp, Chem. Pept. Proteins 1986, 3, 3.
32. a) R. Knorr, A. Trzeciak, W. Baumwarth, D. Gillessen, Tetrahedron Lett. 1989, 30, 1927;
33. b) V. Dourtoglou, B. Gross, V. Lambropoulou, C. Ziondrou, Synthesis 1984, 572;
34. c) W. König, R. Geiger, Chem. Ber. 1970, 103, 788.
35. a) C. Brocke, H. Kunz, Synlett 2003, 2052;
36. b) C. Brocke, H. Kunz, Synthesis 2004, 525.
37. L. A. Carpino, D. Ionescu, A. El-Falham, J. Org. Chem. 1996, 61, 2460.
38. S. S. Wang, J. Am. Chem. Soc. 1973, 95, 1328.
39. 2 to furnish a metastable green radical cation with a maximum absorbance at λ = 414 nm.
40. [2a]
41. For overviews, see, for example: a) C. Brocke, H. Kunz, Bioorg. Med. Chem. 2002, 10, 3085;
42. b) O. Seitz, ChemBioChem 2000, 1, 214;
43. c) H. Herzner, T. Reipen, M. Schultz, H. Kunz, Chem. Rev. 2000, 100, 4495;
44. d) G. Arsequell, G. Valencia, Tetrahedron Asymmetry 1999, 10, 3045.